Patents by Inventor Karim N. Jallad

Karim N. Jallad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8865128
    Abstract: A method of differentiating tumors from healthy cells in tissue is disclosed. The method includes the steps of providing a marker-folate conjugate, placing the marker-folate conjugate in contact with the tissue and viewing the tissue.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: October 21, 2014
    Assignee: Endocyte, Inc.
    Inventors: Karim N. Jallad, Michael D. Kennedy, Philip S. Low, Dor Ben-Amotz
  • Patent number: 8043602
    Abstract: A method of differentiating tumors from healthy cells in tissue is disclosed. The method includes the steps of providing a marker-folate conjugate, placing the marker-folate conjugate in contact with the tissue and viewing the tissue.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: October 25, 2011
    Assignee: Endocyte, Inc.
    Inventors: Karim N. Jallad, Michael D. Kennedy, Philip S. Low, Dor Ben-Amotz
  • Publication number: 20040136910
    Abstract: A method of differentiating tumors from healthy cells in tissue is disclosed. The method includes the steps of providing a marker-folate conjugate, placing the marker-folate conjugate in contact with the tissue and viewing the tissue.
    Type: Application
    Filed: December 19, 2003
    Publication date: July 15, 2004
    Inventors: Karim N. Jallad, Michael D. Kennedy, Philip S. Low, Dor Ben-Amotz
  • Publication number: 20030162234
    Abstract: A method of differentiating tumors from healthy cells in tissue is disclosed. The method includes the steps of providing a marker-folate conjugate, placing the marker-folate conjugate in contact with the tissue and viewing the tissue.
    Type: Application
    Filed: February 6, 2003
    Publication date: August 28, 2003
    Inventors: Karim N. Jallad, Michael D. Kennedy, Philip S. Low, Dor Ben-Amotz